Ribosomal initiation complex assembly within the wild-strain of coxsackievirus B3 and live-attenuated Sabin3-like IRESes during the initiation of translation

International Journal of Molecular Sciences

Volumn 14, Issue 3, 2013, Pages 4400-4418

  Souii, Amira ^a   Ben M'hadheb Gharbi, Manel ^a,b   Sargueil, Bruno ^c   Brossard, Audrey ^c   Chamond, Nathalie ^c   Aouni, Mahjoub ^a   Gharbi, Jawhar ^a,b  

^a Laboratoire des Maladies Transmissibles et Substances Biologiquement Actives (LR99 ES27)   (Tunisia)

^b UNIVERSITY OF MONASTIR   (Tunisia)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

5 UTR; Coxsackievirus B3; IRES; Ribosomal complex assembly; Translation initiation

Indexed keywords

CYCLOHEXIMIDE; GUANYLYLIMIDODIPHOSPHATE; INITIATION FACTOR; RIBOSOME RNA; RNA 48S; RNA 80S; UNCLASSIFIED DRUG; VIRUS RNA;

5' UNTRANSLATED REGION; AMINO ACID SUBSTITUTION; ARTICLE; CODON; COMPLEX FORMATION; CONTROLLED STUDY; COXSACKIE VIRUS B; IN VITRO STUDY; INTERNAL RIBOSOME ENTRY SITE; MOLECULAR CLONING; MUTANT; MUTATIONAL ANALYSIS; NONHUMAN; POINT MUTATION; PROTEIN DOMAIN; PROTEIN RNA BINDING; PROTEIN SECONDARY STRUCTURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSLATION INITIATION; VIRUS STRAIN; WILD TYPE;

EID: 84875068075     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms14034400     Document Type: Article

References (86)

1. Kishimoto, C.; Hiraoka, Y. Clinical and experimental studies in myocarditis. Curr. Opin. Cardiol. 1994, 9, 349-356.
2. Reyes, M.P.; Lerner, A.M. Coxsackievirus myocarditis with special reference to acute and chronic effects. Prog. Cardiovasc. Dis. 1985, 27, 373-394.
3. Woodruff, J.F. Viral myocarditis. A review. Am. J. Pathol. 1980, 101, 425-484.
4. Arnesjo, B.; Eden, T.; Ihse, I.; Nordenfelt, E.; Ursing, B. Enterovirus infections in acute pancreatitis. Scand. J. Gastroenterol. 1976, 11, 645-649.
5. Imrie, C.W.; Ferguson, J.C.; Sommerville, R.G. Coxsackie and mumpsvirus infection in a prospective study of acute pancreatitis. Gut 1977, 18, 53-56.
6. Mena, I.; Fischer, C.; Gebhard, J.R.; Perry, C.M.; Harkins, S.; Whitton, J.L. Coxsackievirus infection of the pancreas: Evaluation of receptor expression, pathogenesis, and immunopathology. Virology 2000, 271, 276-288.
7. Ramsingh, A.I. Coxsackieviruses and pancreatitis. Front. Biosci. 1997, 2, e53-e62.
8. Daley, A.J.; Isaacs, D.; Dwyer, D.E.; Gilbert, G.L. A cluster of cases of neonatal coxsackievirus B meningitis and myocarditis. J. Pediatr. Child. Health 1998, 34, 196-198.
9. Modlin, J.F.; Rotbart, H.A. Group B coxsackie disease in children. Curr. Top. Microbiol. Immunol. 1997, 223, 53-80.
10. Beck, M.A.; Chapman, N.M.; McManus, B.M.; Mullican, J.C.; Tracy, S. Secondary enterovirus infection in the murine model of myocarditis. Pathologic and immunologic aspects. Am. J. Pathol. 1990, 136, 669-681.
11. Esfandiarei, M.; McManus, B.M. Molecular biology and pathogenesis of viral myocarditis. Annu. Rev. Pathol. 2008, 3, 127-155.
12. Kim, K.S.; Hufnagel, G.; Chapman, N.M.; Tracy, S. The group B coxsackieviruses and myocarditis. Rev. Med. Virol. 2001, 11, 355-368.
13. Tu, Z.; Chapman, N.; Hufnagel, G.; Tracy, S.; Romero, J.R.; Barry, W.H.; Zhao, L.; Currey, K.; Shapiro, B. The cardiovirulent phenotype of coxsackievirus B3 is determined at a single site in the Genomic 5′ Nontranslated region. J. Virol. 1995, 69, 4607-4618.
14. Tracy, S.; Chapman, N.M.; Tu, Z. Coxsackievirus B3 from an infectious cDNA copy of the genome is cardiovirulent in mice. Arch. Virol. 1992, 122, 399-409.
15. See, D.M.; Tilles, J.G. Efficacy of a polyvalent inactivated-virus vaccine in protecting mice from infection with clinical strains of group B coxsackieviruses. Scand. J. Infect. Dis. 1994, 26, 739-747.
16. Ben M'hadheb-Gharbi, M.; Gharbi, J.; Paulous S.; Brocard, M.; Komaromva, A.; Aouni, M.; Kean, K.M. Effects of the Sabin-like mutations in domain V of the internal ribosome entry segment on translational efficiency of the Coxsackievirus B3. Mol. Gen. Genomics 2006, 276, 402-412.
17. Ben M'hadheb-Gharbi, M.; Kean, K.M.; Gharbi, J. Molecular analysis of the role of IRES stem-loop V in replicative capacities and translation efficiencies of Coxsackievirus B3 mutants. Mol. Biol. Rep. 2009, 36, 255-262.
18. Dan, M.; Chantler, J.K. A genetically engineered attenuated coxsackievirus B3 strain protects mice against lethal infection. J. Virol. 2005, 79, 9285-9295.
19. Fohlman, J.; Pauksen, K.; Morein, B.; Bjare, U.; Ilbäck, N.G.; Friman, G. High yield production of an inactivated coxsackie B3 adjuvant vaccine with protective effect against experimental myocarditis. Scand. J. Infect. Dis. Suppl. 1993, 88, 103-108.
20. Gauntt, C.J.; Paque, R.E.; Trousdale, M.D.; Gudvangen, R.J.; Barr, D.T.; Lipotich, G.J.; Nealon, T.J.; Duffey, P.S. Temperature-sensitive mutant of coxsackievirus B3 establishes resistance in neonatal mice that protects them during adolescence against coxsackievirus B3-induced myocarditis. Infect. Immun. 1983, 39, 851-864.
21. Henke, A.; Wagner, E.; Whitton, J.L.; Zell, R.; Stelzner, A. Protection of mice against lethal coxsackievirus B3 infection by using DNA immunization. J. Virol. 1998, 72, 8327-8331.
22. Hunziker, I.P.; Cornell, C.T.; Whitton, J.L. Deletions within the 5′UTR of coxsackievirus B3: Consequences for virus translation and replication. Virology 2007, 360, 120-128.
23. Bailey, J.M.; Tapprich, W.E. Structure of the 5′-Nontranslated Region of the coxsackievirus B3 genome: Chemical modification and comparative sequence analysis. J. Virol. 2007, 81, 650-668.
24. Yang, D.; Wilson, J.E.; Anderson, D.R.; Bohunek, L.; Cordeiro, C.; Kandol, R.; Mcmanus, B.M. In vitro mutational and inhibitory analysis of the cis-acting translational elements within the 5′ untranslated region of coxsackievirus B3: Potential targets for antiviral action of antisense oligomers. Virology 1997, 228, 63-73.
25. Ray, P.S.; Das, S. La autoantigen is required for the internal ribosome entry site-mediated translation of Coxsackievirus B3 RNA. Nucleic Acid Res. 2002, 30, 4500-4508.
26. Belsham, G.J.; Sonenberg, N. Picornavirus RNA-translation: Role for cellular proteins. Trends Microbiol. 2000, 8, 330-335.
27. Pestova, T.V.; Hellen, C.U.; Shatsky, I.N. Canonical eukaryotic initiation factors determine initiation of translation by internal ribosomal entry. Mol. Cell. Biol. 1996, 16, 6859-6869.
28. Ventoso, I.; MacMillan, S.E.; Hershey, J.W.; Carrasco, L. Poliovirus 2A proteinase cleaves directly the eIF-4G subunit of eIF-4F complex. FEBS Lett. 1998, 435, 79-83.
29. Jang, S.K.; Krausslich, H.G.; Nicklin, M.J.; Duke, G.M.; Palmenberg, A.C.; Wimmer, E. A segment of the 5′ nontranslated region of encephalomyocarditis virus RNA directs internal entry of ribosomes during in vitro translation. J. Virol. 1988, 62, 2636-2643.
30. Pelletier, J.; Sonenberg, N. Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA. Nature 1988, 334, 320-325.
31. Bedard, K.M.; Daijogo, S.; Semler, B.L. A nucleo-cytoplasmic SR protein functions in viral IRES-mediated translation initiation. EMBO J. 2007, 26, 459-467.
32. Jackson, R.J. Alternative mechanisms of initiating translation of mammalian mRNAs. Biochem. Soc. Trans. 2005, 33, 1231-1241.
33. Pestova, T.V.; Kolupaeva, V.G.; Lomakin, I.B.; Pilipenko, E.V.; Shatsky, I.N.; Agol, V.I.; Hellen, C.U.T. Molecular mechanisms of translation initiation in eukaryotes: Colloquium. Proc. Natl. Acad. Sci. USA 2001, 98, 7029-7036.
34. Hellen, C.U.T.; Sarnow, P. Internal ribosome entry sites in eukaryotic mRNA molecules. Genes Dev. 2001, 15, 1593-1612.
35. Pestova, T.V.; Lomakin, I.B.; Lee, J.H.; Choi, S.K.; Dever, T.E.; Hellen, C.U. The joining of ribosomal subunits in eukaryotes requires eIF5B. Nature 2000, 403, 332-335.
36. Anthony, D.D.; Merrick, W.C. Eukaryotic initiation factor (eIF)-4F. Implications for a role in internal initiation of translation. J. Biol. Chem. 1991, 266, 10218-10226.
37. Ochs, K.; Rust, R.C.; Niepmann, M. Translation initiation factor eIF4B interacts with a picornavirus internal ribosome entry site in both 48S and 80S Initiation complexes independently of initiator AUG location. J. Virol. 1999, 73, 7505-7514.
38. Pause, A.; Méthot, N.; Svitkin, Y.; Merrick, W.C.; Sonenberg, N. Dominant negative mutants of mammalian translation initiation factor eIF-4A define a critical role for eIF-4F in cap-dependent and cap-independent initiation of translation. EMBO J. 1994, 13, 1205-1215.
39. Pestova, T.V.; Shatsky, I.N.; Fletcher, S.P.; Jackson, R.J.; Hellen, C.U. A prokaryotic-like mode of cytoplasmic eukaryotic ribosome binding to the initiation codon during internal translation initiation of hepatitis C and classical swine fever virus RNAs. Genes Dev. 1998, 12, 67-83.
40. Flanegan, J.B.; Pettersson, R.F.; Ambros, V.; Hewlett, N.J.; Baltimore, D. Covalent linkage of a protein to a defined nucleotide sequence at the 5′-terminus of virion and replicative intermediate RNAs of poliovirus. Proc. Natl. Acad. Sci. USA 1977, 74, 961-965.
41. Lee, Y.F.; Nomoto, A.; Detjen, B.M.; Wimmer, E. A protein covalently linked to poliovirus genome RNA. Proc. Natl. Acad. Sci. USA 1977, 74, 59-63.
42. Etchison, D.; Milburn, S.C.; Edery, I.; Sonenberg, N.; Hershey, J.W. Inhibition of HeLa cell protein synthesis following poliovirus infection correlates with the proteolysis of a 220.000-dalton polypeptide associated with eucaryotic initiation factor 3 and a cap binding protein complex. J. Biol. Chem. 1982, 257, 14806-14810.
43. Krausslich, H.G.; Nicklin, M.J.; Toyoda, H.; Etchison, D.; Wimmer, E. Poliovirus proteinase 2A induces cleavage of eucaryotic initiation factor 4F polypeptide p220. J. Virol. 1987, 61, 2711-2718.
44. La Monica, N.; Racaniello, V.R. Differences in replication of attenuated and neurovirulent polioviruses in human neuroblastoma cell line SH-SY5Y. J. Virol. 1989, 63, 2357-2560.
45. Svitkin, Y.V.; Cammack, N.; Minor, P.D.; Almond, J.W. Translation deficiency of the Sabin type 3 poliovirus genome: Association with an attenuating mutation C472-U. Virology 1990, 175, 103-109.
46. Malnou, E.C.; Werner, A.; Borman, M.A.; Westhof, E.; Kean, M.K. Effects of vaccine strain mutations in domain V of the internal ribosome entry segment compared in the wild type poliovirus type 1 context. J. Biol. Chem. 2004, 279, 10261-10269.
47. Poehlsgaard, J.; Douthwaite, S. The bacterial ribosome as a target for antibiotics. Nat. Rev. Microbiol. 2005, 3, 870-881.
48. Fernandez, J.; Yaman, I.; Huang, C.; Liu, H.; Lopez, A.B.; Komar, A.A.; Caprara, M.G.; Merrick, W.C.; Snider, M.D.; Kaufman, R.J, et al. Ribosome Stalling Regulates IRES-Mediated Translation in Eukaryotes, a Parallel to Prokaryotic Attenuation. Mol. Cell. 2005, 17, 405-416.
49. Obrig, T.G.; Culp, W.J.; McKeehan, W.L.; Hardesty, B. The mechanism by which cycloheximide and related glutarimide antibiotics inhibit peptide synthesis on reticulocyte ribosomes. J. Biol. Chem. 1971, 246, 174-181.
50. Schneider-Poetsch, T.; Ju, J.; Eyler, E.; Dang, Y.; Bhat, S.; Merrick, W.C.; Green, R.; Shen, B.; Liu, J.O. Inhibition of eukaryotic translation elongation by cycloheximide and lactimidomycin. Nat. Chem. Biol. 2010, 6, 209-217.
51. Met ternary complex availability. Mol. Biol. Cell. 2006, 17, 4632-4644.
52. Chan, J.; Khan, S.N.; Harvey, I.; Merrick, W.; Pelletier, J. Eukaryotic protein synthesis inhibitors identified by comparison of cytotoxicity profiles. RNA 2004, 10, 528-543.
53. Kapp, L.D.; Lorsch, J.R. The molecular mechanics of eukaryotic translation. Annu. Rev. Biochem. 2004, 73, 657-704.
54. Low, W.K.; Dang, Y.; Schneider-Poetsch, T.; Shi, Z.; Choi, N.S.; Merrick, W.C.; Romo, D.; Liu, J.O. Inhibition of Eukaryotic Translation Initiation by the Marine Natural Product Pateamine A. Mol. Cell. 2005, 20, 709-722.
55. Jackson, R.J.; Hellen, C.U.; Pestova, T.V. The mechanism of eukaryotic translation initiation and principles of its regulation. Nat. Rev. Mol. Cell. Biol. 2010, 11, 113-127.
56. Sonenberg, N.; Hinnebusch, A.G. Regulation of translation initiation in eukaryotes: Mechanisms and biological targets. Cell. 2009, 136, 731-745.
57. Fitzgerald, K.D.; Semler, B.L. Bridging IRES elements in mRNAs to the eukaryotic translation apparatus. Biochem. Biophys. Acta. 2009, 1789, 518-528.
58. López-Lastra, M.; Rivas, A.; Barria, M.I. Protein synthesis in eukaryotes: The growing biological relevance of cap-independent translation initiation. Biol. Res. 2005, 38, 121-146.
59. Vallejos, M.; Deforges, J.; Plank, T.D.M.; Letelier, A.; Ramdohr, P.; Abraham, C.G.; Valiente-Echeverrìa, F.; Kieft, J.S.; Sargueil, B.; López-Lastra, M. Activity of the human immunodeficiency virus type 1 cell cycle-dependent internal ribosomal entry site is modulated by IRES trans-acting factors. Nucleic Acid Res. 2011, 39, 6186-6200.
60. Chen, T.C.; Weng, K.F.; Chang, S.C.; Lin, J.Y.; Huang, P.N.; Shih, S.R. Development of antiviral agents for enteroviruses. J. Antimicrob. Chemother. 2008, 62, 1169-1173.
61. Liu, Z.; Carthy, C.M.; Cheung, P.; Bohunek, L.; Wilson, J.E.; McManus, B.M.; Yang, D. Structural and functional analysis of the 5′untranslated region of coxsackievirus B3 RNA: In vivo translational and infectivity studies of full-length mutants. Virology 1999, 265, 206-217.
62. 473→C with Sabin3-like mutation within the IRES attenuate coxsackievirus B3 cardiovirulence. Mol. Biotechnol. 2007, 36, 52-60.
63. Bhattacharyya, S.; Das, S. Mapping of secondary structure of the spacer region within the 5′-untranslated region of the coxsackievirus B3 RNA: Possible role of an apical GAGA loop in binding La protein and influencing internal initiation of translation. Virus Res. 2005, 108, 89-100.
64. Verma, B.; Ponnuswamy, A.; Gnanasundram, S.V.; Das, S. Cryptic AUG is important for 48S ribosomal assembly during internal initiation of translation of coxsackievirus B3 RNA. J. Gen. Virol. 2011, 92, 1-10.
65. King, H.A.; Cobbold, L.C.; Willis, A.E. The role of IRES trans-acting factors in regulating translation initiation. Biochem. Soc. Trans. 2010, 38, 1581-1586.
66. Semler, B.L.; Waterman, M.L. IRES-mediated pathways to polysomes: Nuclear versus cytoplasmic routes. Trends Microbiol. 2008, 16, 1-5.
67. Ochs, K.; Zeller, A.; Saleh, L.; Bassili, G.; Song, Y.; Sonntag, A.; Niepmann, M. Impaired binding of standard initiation factors mediates poliovirus translation attenuation. J. Virol. 2003, 77, 115-122.
68. Pestova, T.V.; Hellen, C.U.T.; Wimmer, E. A conserved AUG triplet in the 5′ nontranslated region of poliovirus can function as an initiation codon in vitro and in vivo. Virology 1994, 204, 729-737.
69. Poyry, T.A.; Hentze, M.W.; Jackson, R.J. Construction of regulatable picornavirus IRESes as a test of current models of the mechanism of internal translation initiation. RNA 2001, 7, 647-660.
70. Iizuka, N.; Yonekawa, H.; Nomoto, A. Nucleotide sequences important for translation initiation of enterovirus RNA. J. Virol. 1991, 65, 4867-4873.
71. Yang, D.; Cheung, P.; Sun, Y.; Yuan, J.; Zhang, H.; Carthy, C.M.; Anderson, D.R.; Bohunek, L.; Wilson, J.E.; Mcmanus, B.M. A Shine-Dalgarno-like sequence mediates in vitro ribosomal internal entry and subsequent scanning for translation initiation of coxsackievirus B3 RNA. Virology 2003, 305, 31-43.
72. Locker, N.; Easton, L.E.; Lukavsky, P.J. HCV and CSFV IRES domain II mediate eIF2 release during 80S ribosome assembly. EMBO J. 2007, 26, 795-805.
73. Lukavsky, P.J. Structure and function of HCV IRES domains. Virus Res. 2009, 139, 166-171.
74. Pestova, T.V.; de Breyne, S.; Pisarev, A.V.; Abaeva, I.S.; Hellen, C.U. eIF2-dependent and eIF2-independent modes of initiation on the CSFV IRES: A common role of domain II. EMBO J. 2008, 27, 1060-1072.
75. Vagner, S.; Galy, B.; Pyronnet, S. Irresistible IRES. Attracting the translation machinery to internal ribosome entry sites. EMBO Rep. 2001, 10, 893-898.
76. Verma, B.; Bhattacharyya, S.; Das, S. Polypyrimidine tract binding protein interacts with coxsackievirus B3 RNA and influences its translation. J. Gen. Virol. 2010, 91, 1245-1255.
77. Zell, R.; Ihle, Y.; Seitz, S.; Gündel, U.; Wutzler, P.; Görlach, M. Poly (rC)-binding protein 2 interacts with the oligo (rC) tract of coxsackievirus B3. Biochem. Biophys. Res. Commun. 2008, 366, 917-921.
78. Henis-Korenblit, S.; Shani, G.; Sines, T.; Marash, L.; Shohat, G.; Kimchi, A. The caspase-cleaved DAP5 protein supports internal ribosome entry site mediated translation of death proteins. Proc. Natl. Acad. Sci. USA 2002, 99, 5400-5405.
79. Skinner, M.; Racaniello, V.; Dunn, G.; Cooper, J.; Minor, P.D.; Almond, J.W. New model for the secondary structure of the 5′ non-coding RNA of poliovirus is supported by biochemical and genetic data that also show that RNA secondary structure is important in neurovirulence. J. Mol. Biol. 1989, 207, 379-392.
80. Pilipenko, E.V.; Gmyl, A.P.; Maslova, S.V.; Svitkin, Y.V.; Sinyakov, A.N.; Agol, V.I. Prokaryotic-like cis elements in the cap independent internal initiation of translation on picornavirus RNA. Cell 1992, 68, 119-131.
81. Bhattacharyya, S.; Verma, B.; Pandey, G.; Das, S. The structure and function of a cis-acting element located upstream of the IRES that influences Coxsackievirus B3 RNA translation. Virology 2008, 377, 345-354.
82. López de Quinto, S.; Martínez-Salas, E. Conserved structural motifs located in distal loops of aphthovirus internal ribosome entry site domain 3 are required for internal initiation of translation. J. Virol. 1997, 71, 4171-4175.
83. Malnou, C.E.; Pöyry, T.A.; Jackson, R.J.; Kean, K.M. Poliovirus internal ribosome entry segment structure alterations that specifically affect function in neuronal cells: Molecular genetic analysis. J. Virol. 2002, 76, 10617-10626.
84. Fernández-Miragall, O.; Martínez-Salas, E. Structural organization of a viral IRES depends on the integrity of the GNRA motif. RNA 2003, 9, 1333-1344.
85. Bhattacharyya, S.; Das, S. An apical GAGA loop within 5′UTR of the coxsackievirus B3 RNA maintains structural organization of the IRES element required for efficient ribosome entry. RNA Biol. 2006, 3, 60-68.
86. Chomczynski, P.; Sacchi, N. Single-step method of RNA isolation by Acid Guanidium thiocyanate-phenol-Chloroform extraction. Anal. Biochem. 1987, 162, 156-159.